BMS 527
Generic Name: dasatinib
Pill imprint BMS 527 has been identified as Sprycel 20 mg.
Sprycel is used in the treatment of chronic myelogenous leukemia; leukemia; acute lymphoblastic leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy.
Sprycel 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Sprycel Images
- Generic Name:
- dasatinib
- Imprint:
-
BMS
527 - Strength:
- 20 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-0527
Advertisement
More Sprycel resources
Search Again
